Tamper-resistant prescription pads available through new Standard Register Web site
DAYTON, Ohio Standard Register, a provider of secure prescriptions, has launched a Web site called www.securescrip.com, which is used for ordering the company’s full line of tamper-resistant prescription pads.
The site provides secure order entry online, automatic medical license validation and online proofs, in addition to giving practitioners the ability to check order status and track shipments.
“The securescrip site brings together both convenience and security,” said Jay Frerichs, program director for Standard Register’s prescription program. “Standard Register has a long history of providing security to ensure prescription pads do not fall into unauthorized hands. We also employ effective internal controls, the highest security standards and tightest quality procedures to handle sensitive, customer data, such as physician’s credit card information.”
The site also offers free shipping on all online Rx pad orders.
ScriptPro robotic dispensing adopted in two Haggen locations
BELLINGHAM, Washington Haggen Food & Pharmacy has added ScriptPro’s robotic dispensing devices to two of its stores, one in Ferndale and the other in Barkley Village, according to published reports.
The system automatically selects a prescription vial, counts tablets or capsules into the vial and labels it with patient, drug and dosing information.
“This system offers many advantages for our customers,” said Andrew Charter, vice president of pharmacy at Haggen Inc. “It is better than partially automated systems in providing accurately counted doses. Most importantly, it frees up our pharmacists to spend more time answering the questions of customers rather than counting pills or making labels.”
Eli Lilly, Sanofi-Aventis partner to market Cialis
BRDIGEWATER, N.J. Sanofi-Aventis has agreed to help Eli Lilly market its impotency drug Cialis, according to CNN. Financial terms were not disclosed.
Lilly gained full rights to the medicine at the beginning of 2007, when it bought the drug from ICOS for $2.3 billion.
Cialis had worldwide sales of $1.1 billion in 2007, compared with its main competitor Pfizer’s Viagra, which saw sales of $1.76 billion.